| # | Title | Journal | Year | Citations |
|---|
| 1 | RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES | Nauchno-Prakticheskaya Revmatologiya | 0 | 110 |
| 2 | SF-36 questionnaire population quality of life indices Objective | Nauchno-Prakticheskaya Revmatologiya | 2008 | 52 |
| 3 | Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects | Nauchno-Prakticheskaya Revmatologiya | 2019 | 45 |
| 4 | CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS | Nauchno-Prakticheskaya Revmatologiya | 2020 | 43 |
| 5 | Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia | Nauchno-Prakticheskaya Revmatologiya | 2021 | 40 |
| 6 | ON THE TERMINOLOGY OF SPONDYLOARTHRITIS | Nauchno-Prakticheskaya Revmatologiya | 2015 | 40 |
| 7 | PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: NEW STRATEGY, NEW TARGETS | Nauchno-Prakticheskaya Revmatologiya | 2017 | 40 |
| 8 | RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE | Nauchno-Prakticheskaya Revmatologiya | 2018 | 38 |
| 9 | INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES | Nauchno-Prakticheskaya Revmatologiya | 2017 | 37 |
| 10 | ROLE OF INTERLEUKIN 1 IN THE DEVELOPMENT OF HUMAN DISEASES | Nauchno-Prakticheskaya Revmatologiya | 2016 | 33 |
| 11 | THE INCIDENCE OF MUSCULOSKELETAL DISEASES IN THE RUSSIAN FEDERATION OVER 2015–2016 | Nauchno-Prakticheskaya Revmatologiya | 2018 | 33 |
| 12 | Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity | Nauchno-Prakticheskaya Revmatologiya | 2020 | 33 |
| 13 | Coronavirus disease 2019 (COVID-19) and autoimmunity | Nauchno-Prakticheskaya Revmatologiya | 2021 | 28 |
| 14 | NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17 | Nauchno-Prakticheskaya Revmatologiya | 2017 | 28 |
| 15 | Structure of rheumatic diseases among adult population of Russia according to data of an epidemiological study (preliminary results) | Nauchno-Prakticheskaya Revmatologiya | 2009 | 27 |
| 16 | ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE) | Nauchno-Prakticheskaya Revmatologiya | 2014 | 27 |
| 17 | IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE | Nauchno-Prakticheskaya Revmatologiya | 2019 | 27 |
| 18 | PROBLEMS OF RHEUMATOID ARTHRITIS IMMUNOPATHOLOGY: EVOLUTION OF THE DISEASE | Nauchno-Prakticheskaya Revmatologiya | 2017 | 26 |
| 19 | GUIDELINES FOR THE ASSESSMENT OF DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE | Nauchno-Prakticheskaya Revmatologiya | 2017 | 25 |
| 20 | A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG | Nauchno-Prakticheskaya Revmatologiya | 2014 | 24 |
| 21 | THE INCIDENCE AND PREVALENCE OF RHEUMATIC DISEASES IN RUSSIA IN 2012–2013 | Nauchno-Prakticheskaya Revmatologiya | 2015 | 23 |
| 22 | PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES | Nauchno-Prakticheskaya Revmatologiya | 0 | 23 |
| 23 | METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS | Nauchno-Prakticheskaya Revmatologiya | 2015 | 23 |
| 24 | Prevalence of rheumatic diseases in adult populations of Russian Federation and USA | Nauchno-Prakticheskaya Revmatologiya | 2008 | 21 |
| 25 | PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT | Nauchno-Prakticheskaya Revmatologiya | 2018 | 21 |
| 26 | Validation of general questionnaire EuroQol-5D (EQ-5D) Russian version | Nauchno-Prakticheskaya Revmatologiya | 2007 | 20 |
| 27 | THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY) | Nauchno-Prakticheskaya Revmatologiya | 2016 | 20 |
| 28 | MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG | Nauchno-Prakticheskaya Revmatologiya | 2013 | 19 |
| 29 | PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES | Nauchno-Prakticheskaya Revmatologiya | 2016 | 19 |
| 30 | BIOSIMILARS IN RHEUMATOLOGY | Nauchno-Prakticheskaya Revmatologiya | 2017 | 19 |
| 31 | Alflutop efficacy in chronic vertebrogenous lumbar ischialgia. A double blind placebo controlled study | Nauchno-Prakticheskaya Revmatologiya | 2004 | 18 |
| 32 | THE CONCEPT OF MULTIMORBIDITY IN RHEUMATOLOGIC PRACTICE | Nauchno-Prakticheskaya Revmatologiya | 2014 | 18 |
| 33 | DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES | Nauchno-Prakticheskaya Revmatologiya | 2017 | 18 |
| 34 | USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND BIOLOGICAL AGENTS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIDES. RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA» | Nauchno-Prakticheskaya Revmatologiya | 2017 | 18 |
| 35 | OSTEOARTHRITIS: CURRENT CLINICAL CONCEPT AND SOME PROMISING THERAPEUTIC APPROACHES | Nauchno-Prakticheskaya Revmatologiya | 2018 | 18 |
| 36 | “Post-COVID syndrome”: The focus is on musculoskeletal pain | Nauchno-Prakticheskaya Revmatologiya | 2021 | 17 |
| 37 | The role of interleukin 1 in the development of human diseases | Nauchno-Prakticheskaya Revmatologiya | 0 | 17 |
| 38 | Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I) | Nauchno-Prakticheskaya Revmatologiya | 2020 | 17 |
| 39 | Clinical diversity of ankylosing spondylitis in the real practice of a rheumatologist in Russia (Part 1) | Nauchno-Prakticheskaya Revmatologiya | 2012 | 17 |
| 40 | NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB | Nauchno-Prakticheskaya Revmatologiya | 2014 | 17 |
| 41 | Trends in the prevalence of rheumatic diseases in ICD-10 in the adult population of the Russian Federation over 2000-2010 | Nauchno-Prakticheskaya Revmatologiya | 2012 | 16 |
| 42 | THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS | Nauchno-Prakticheskaya Revmatologiya | 2017 | 16 |
| 43 | AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE | Nauchno-Prakticheskaya Revmatologiya | 2016 | 16 |
| 44 | Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders | Nauchno-Prakticheskaya Revmatologiya | 2019 | 16 |
| 45 | IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6 | Nauchno-Prakticheskaya Revmatologiya | 2020 | 16 |
| 46 | Systemic lupus erythematosus: new horizons for diagnosis and therapy | Nauchno-Prakticheskaya Revmatologiya | 2020 | 16 |
| 47 | UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS | Nauchno-Prakticheskaya Revmatologiya | 2017 | 16 |
| 48 | CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA | Nauchno-Prakticheskaya Revmatologiya | 2016 | 15 |
| 49 | INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE | Nauchno-Prakticheskaya Revmatologiya | 2017 | 15 |
| 50 | GASTROINTESTINAL BLEEDING WITH THE USE OF NEW ORAL ANTICOAGULANTS: EPIDEMIOLOGY, RISK FACTORS, TREATMENT, AND PREVENTION | Nauchno-Prakticheskaya Revmatologiya | 2017 | 15 |
